Namekata Kazuhiko, Nishimura Noriyuki, Kimura Hideo
National Institute of Neuroscience, NCNP, Tokyo, Japan.
J Neurochem. 2002 Aug;82(4):819-27. doi: 10.1046/j.1471-4159.2002.01039.x.
A novel presenilin-binding protein (PBP) is specifically expressed in the brain, and its level in the soluble fraction of Alzheimer's disease (AD) brains is much less than that in the age-matched controls. Recently, several proteins, including presenilin (PS), have been found to form structures of aggregated proteins, called aggresomes, when the production of the proteins exceeds their rate of degradation by proteasomes. Based on these observations it has been proposed that the aggresome may represent one of the mechanisms forthe formation of cytoplasmic deposits which are linked to the pathogenesis of neurodegenerative disorders including AD. It is shown here that the overexpression of PBP or the suppression of proteasome activity in monkey kidney COS-7 cells leads to the accumulation of detergent-insoluble and multiubiquitinated PBP aggregates. PBP also forms aggregates in primary cultures of neurons in the presence of a proteasome inhibitors. PBP aggregates have the characteristics of aggresomes, including the localization to microtubule organization centers and the disruption of intermediate filaments. These observations suggest that the malfunctioning of the proteasome can cause the formation of PBP aggresomes, which may lead to AD.
一种新型早老素结合蛋白(PBP)在大脑中特异性表达,其在阿尔茨海默病(AD)脑可溶性部分中的水平远低于年龄匹配的对照组。最近,人们发现包括早老素(PS)在内的几种蛋白质,当蛋白质的产生超过蛋白酶体对其降解速度时,会形成称为聚集体的聚集蛋白结构。基于这些观察结果,有人提出聚集体可能是与包括AD在内的神经退行性疾病发病机制相关的细胞质沉积物形成机制之一。本文表明,在猴肾COS-7细胞中过表达PBP或抑制蛋白酶体活性会导致去污剂不溶性和多泛素化的PBP聚集体积累。在蛋白酶体抑制剂存在的情况下,PBP在原代神经元培养物中也会形成聚集体。PBP聚集体具有聚集体的特征,包括定位于微管组织中心和破坏中间丝。这些观察结果表明,蛋白酶体功能异常可导致PBP聚集体的形成,这可能导致AD。